Company Valuation: Abbott Laboratories

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 241,365 191,427 191,088 196,184 217,859 181,137 - -
Change - -20.69% -0.18% 2.67% 11.05% -16.86% - -
Enterprise Value (EV) 1 249,166 198,318 198,871 202,693 222,266 205,076 202,094 198,403
Change - -20.41% 0.28% 1.92% 9.66% -7.73% -1.45% -1.83%
P/E 35.7x 28.1x 33.8x 14.8x 33.7x 30.9x 23.9x 21x
PBR 6.93x 5.2x 4.94x 4.11x 4.18x 3.78x 3.62x 3.44x
PEG - -36.9x -2x 0x -0.7x -3.48x 0.8x 1.5x
Capitalization / Revenue 5.6x 4.39x 4.76x 4.68x 4.91x 3.61x 3.32x 3.11x
EV / Revenue 5.78x 4.54x 4.96x 4.83x 5.01x 4.09x 3.71x 3.41x
EV / EBITDA 19.4x 15.9x 19.5x 19.1x 18.9x 15.8x 14x 12.5x
EV / EBIT 22x 17.7x 22.3x 21.8x 21.6x 17.5x 15.5x 13.9x
EV / FCF 28.8x 25.4x 39.3x 31.9x 30.1x 27.2x 22.7x 20.7x
FCF Yield 3.47% 3.94% 2.54% 3.13% 3.33% 3.68% 4.41% 4.83%
Dividend per Share 2 1.82 1.92 2.08 2.24 2.4 2.57 2.741 2.898
Rate of return 1.29% 1.75% 1.89% 1.98% 1.92% 2.46% 2.62% 2.77%
EPS 2 3.94 3.91 3.26 7.64 3.72 3.389 4.374 4.986
Distribution rate 46.2% 49.1% 63.8% 29.3% 64.5% 75.8% 62.7% 58.1%
Net sales 1 43,075 43,653 40,109 41,950 44,328 50,197 54,525 58,249
EBITDA 1 12,815 12,485 10,188 10,635 11,735 12,985 14,467 15,891
EBIT 1 11,324 11,231 8,911 9,295 10,301 11,721 13,019 14,316
Net income 1 7,071 6,933 5,723 13,402 6,524 6,163 7,843 8,710
Net Debt 1 7,801 6,891 7,783 6,509 4,407 23,939 20,957 17,267
Reference price 2 140.74 109.79 110.07 113.11 125.29 104.68 104.68 104.68
Nbr of stocks (in thousands) 1,714,968 1,743,574 1,736,059 1,734,455 1,738,834 1,730,383 - -
Announcement Date 26/1/22 25/1/23 24/1/24 22/1/25 22/1/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
30.89x4.09x15.79x2.46% 181B
20.43x3.54x12.67x2.95% 117B
22.83x4.47x15.61x1.23% 112B
26.34x2.59x10.38x2.72% 76.56B
18.73x0.22x13.57x0.7% 65.15B
30.39x7.54x19.43x1.32% 52.79B
37.34x3.56x12.2x2.02% 52.78B
37.06x9.21x25.79x-.--% 43.11B
49.13x1.34x12.46x0.2% 32.08B
35.24x6.18x19.41x-.--% 33.1B
Average 30.84x 4.27x 15.73x 1.36% 76.6B
Weighted average by Cap. 28.33x 4.05x 15.14x 1.78%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Abbott Laboratories

Historical PBR trend

Valuation ratios - PBR - Abbott Laboratories

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Abbott Laboratories

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Abbott Laboratories


Year-on-year evolution of the Yield

Valuation ratios - Yield - Abbott Laboratories
  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. Valuation Abbott Laboratories